US FDA Searches For Consistency On Assessment Of Real-World Evidence

As more sponsors begin using RWE, the agency is establishing procedures and training to ensure assessors consistently apply policies.

Archery
The US FDA is employing a similar approach to ensure assessor consistency as it did with rare diseases.

More from Approval Standards

More from Pathways & Standards